Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
Tumori
; 107(1): 6-11, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-1067070
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has stressed the importance of health research as never before. In the specific domain of clinical research, the effort to rapidly find responses to health challenges and therapeutic hypotheses has highlighted the need for efficient, timely, ethically correct research. The guidelines published by the Agenzia Italiana del Farmaco have shown that some useful changes are feasible simple and rapid methods have been implemented to conduct clinical research in the emergency conditions of the pandemic, maintaining high levels of quality. In this perspective, four Italian scientific associations operating in clinical research have worked together to evaluate which measures, among the ones implemented during the pandemic, have been particularly significant and potentially effective under normal conditions or in case of emergencies, and that therefore will be useful in the future as well.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Biomedical Research
/
SARS-CoV-2
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Tumori
Year:
2021
Document Type:
Article
Affiliation country:
0300891620977916
Similar
MEDLINE
...
LILACS
LIS